Fingerprint
Dive into the research topics of 'Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
Gary R. Cutter, Olaf Stüve
Research output: Contribution to journal › Review article › peer-review
39
Scopus
citations